Zyla Life Sciences Debt Instrument, Convertible, Beneficial Conversion Feature
Zyla Life Sciences reported Debt Instrument, Convertible, Beneficial Conversion Feature of $5.00 million for the 12-month period ending 2013-12-31, per its 10-K filed 2016-03-11.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature · last filed 2016-03-11
- Zyla Life Sciences debt instrument, convertible, beneficial conversion feature for the quarter ending 2013-12-31 was $0.00.
- Zyla Life Sciences debt instrument, convertible, beneficial conversion feature for fiscal 2013 was $5.00M.
| Period end | Debt Instrument, Convertible, Beneficial Conversion Feature 3 month | Debt Instrument, Convertible, Beneficial Conversion Feature 9 month | Debt Instrument, Convertible, Beneficial Conversion Feature 12 month |
|---|---|---|---|
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $5.00M 10-K · filed 2016-03-11 | |
| 2013-09-30 | $5.00M 10-Q · filed 2014-11-14 |